← Open Payments lookup

ABDUL HAMEED: Open Payments

NPI 1750395331 · CAIRO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$314 in 15 payments from 7 companies in 2025. Trend: 2023 $313 · 2024 $168 · 2025 $314

Food & beverage: $314
CompanyPaymentsAmount
Alkermes, Inc.3$75
Janssen Pharmaceuticals, Inc3$63
ABBVIE INC.3$57
Neurocrine BioSciences, Inc.2$40
E.R. Squibb & Sons, L.L.C.2$32
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$29
Teva Pharmaceuticals USA, Inc.1$18

Products named: INVEGA SUSTENNA, VRAYLAR, VIVITROL, INGREZZA, COBENFY, ARISTADA, CAPLYTA, AUSTEDO XR.

Industry payments across NY — which companies pay providers there.